AngioDynamics
ANGO • NASDAQ
AngioDynamics is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO James C. Clemmer, with a market cap of $449.3M.
CEOJames C. Clemmer
Next Earnings
Upcoming earnings announcement for AngioDynamics
Date
Thursday, April 2, 2026 (in 3 days)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q3 2026
EPS Estimate
-$0.11
Revenue Estimate
$77.0M
Earnings History
Past 12 earnings reports for AngioDynamics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Jan 6, 2026 | Q2 2026 | $0.00Est: -$0.10 | +100.0% | $79.4MEst: $76.3M | +4.1% |  10-Q |
| Oct 2, 2025 | Q1 2026 | -$0.10Est: -$0.13 | +23.1% | $75.7MEst: $72.5M | +4.4% | 10-Q |
| Jul 15, 2025 | Q4 2025 | -$0.03Est: -$0.12 | +75.0% | $80.2MEst: $74.4M | +7.8% | 10-K |
| Apr 2, 2025 | Q3 2025 | -$0.08Est: -$0.13 | +38.5% | $72.0MEst: $70.3M | +2.4% | 10-Q |
| Jan 8, 2025 | Q2 2025 | -$0.04Est: -$0.11 | +63.6% | $72.8MEst: $70.9M | +2.7% | 10-Q |
| Oct 3, 2024 | Q1 2025 | -$0.11Est: -$0.15 | +26.7% | $67.5MEst: $67.9M | -0.6% | 10-Q |
| Jul 16, 2024 | Q4 2024 | -$0.06Est: -$0.16 | +62.5% | $71.0MEst: $70.9M | +0.1% | 10-K |
| Apr 4, 2024 | Q3 2024 | -$0.16Est: -$0.13 | -23.1% | $75.2MEst: $75.7M | -0.7% | 10-Q |
| Jan 5, 2024 | Q2 2024 | -$0.05Est: -$0.07 | +28.6% | $79.1MEst: $82.0M | -3.6% | 10-Q |
| Oct 4, 2023 | Q1 2024 | -$0.12Est: -$0.13 | +7.7% | $78.7MEst: $77.7M | +1.3% | 10-Q |
| Jul 12, 2023 | Q4 2023 | $0.02Est: $0.02 | 0.0% | $91.1MEst: $90.7M | +0.4% | — |
| Mar 30, 2023 | Q3 2023 | -$0.03Est: -$0.01 | -200.0% | $80.7MEst: $83.2M | -3.0% | — |